Susan G. Komen Central and South Jersey is a primary resource for women in our 13-county service area who need breast cancer screening, diagnostic and support services. Through annual events including the Race for the Cure® and individual contributions from donors like you, Komen Central and South Jersey raises funds to support breast health services for women who would not otherwise have access.
In addition to funding breast health programs, the Affiliate also serves as a local resource for patients in need, performs outreach in the form of breast health presentations, advocates for public policy at the local, state and national level, and spearheads an initiative to reach breast cancer survivors.
Where does the money go?
We know our donors work extremely hard to raise money and that often it is for very personal reasons. That is why we make it a priority to honor those efforts by supporting quality community programs and research that will have the greatest impact on breast cancer.
Seventy-five percent (75%) of all funds raised by the Affiliate goes directly to support our Community Grants Program. Twenty-five percent (25%) of funds raised supports the Susan G. Komen® Global Research Program. Every day we are on a mission.
Community Grants Program
Since 1998, Komen Central and South Jersey has raised nearly $16 million for local community grants. This year, we awarded $600,000 in grants to 10 local organizations that serve the breast health needs of uninsured, underinsured and low-income residents through a combination of:
- Breast cancer education
- Free breast cancer screening and/or diagnostic services
- Mobile mammography
- Patient navigation
- Transportation services
- Translation services
The grants awarded this year will provide support services to more than 10,000 individuals, including patient navigation, breast health education, transportation and financial assistance, and screening mammograms to 950 individuals. Click here to see a full list of our current grant recipients and descriptions of their programs.
Susan G. Komen® Global Research Program
This year, Komen Central and South Jersey invested $275,000 toward Susan G. Komen® Global Research Program – our total research investment since 2005 is $5.5 million.
The Susan G. Komen® Global Research Program funds lifesaving research in all areas of breast cancer, from basic biology to prevention to treatment and to survivorship in the United States and across the globe. And with continued support, this scientific research will address some of the most pressing issues in breast cancer today:
- Identifying and improving methods of early detection
- Ensuring more accurate diagnoses
- Developing new approaches to prevention
- Enabling personalized treatments based on breast cancer subtypes and the genetic make-up of a tumor
We have made a promise to end breast cancer forever – energizing science to find the cures is a critical part of this promise. Because of medical research, the death rate for breast cancer is 30 percent lower than it was 25 years ago and more than 3 million women are breast cancer survivors today.
To learn about Komen-funded research in New Jersey, click here.
Susan G. Komen National Treatment Assistance Fund
Komen Central and South Jersey contributed $25,000 to Komen’s National Treatment Assistance Program for 2018, with funds earmarked to provide direct financial assistance for patients in Central and South Jersey who are struggling with the crippling costs associated with their breast cancer treatment.
The Susan G. Komen Treatment Assistance Fund supports those who are facing financial challenges by providing limited financial assistance, education and support services to low-income, underinsured or uninsured breast cancer patients. Financial assistance is available for breast cancer treatment expenses such as oral pain medication, anti-nausea medication, oral chemotherapy/hormone therapy, child care/elder care, transportation to and from treatment, lymphedema care and supplies and durable medical equipment.
To learn more about this program and eligibility requirements, click here.